Fabry : National Initiative of Screening "FIND"


Phase N/A Results N/A

Summary of Purpose

Fabry disease is a genetic disease due to an enzymatic deficit. A screening of this disease allows patients to benefit from an enzyme replacement therapy and prevent the occurrence of life threatening manifestations such as an ischemic stroke. The purpose of the study is to determinate the prevalence of Fabry disease in a population of male patients hospitalized for an ischemic stroke. This study, with a...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 December 2009.

1 Mar 2007 8 Jun 2007 1 Dec 2008 1 Dec 2009 1 Dec 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Subject)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Single Group Assignment


Not available